tiprankstipranks
Trending News
More News >
Advertisement

JP:2624 ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
14Bullish
5Neutral
3Bearish
Oscillators
Sell
2Bullish
5Neutral
3Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Moving Averages Convergence Divergence (MACD) indicator is 130.34, suggesting iFreeETF-Nikkei225(Quarterly Dividend Type) is a Sell.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 20-Day exponential moving average is 4710.42, making it a Buy.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 50-Day exponential moving average is 4493.01, making it a Buy.

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Pivot Points

Oct 22, 2025, 02:53 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4,724.33
4,748.67
4,786.33
4,810.67
4,848.33
4,872.67
4,910.33
Fibonacci
4,748.67
4,772.35
4,786.98
4,810.67
4,834.35
4,848.98
4,872.67

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Moving Averages

Oct 22, 2025, 02:53 AM
Period
Simple
Exponential
MA5
4,826.00Buy
4,863.25Buy
MA10
4,844.39Buy
4,809.84Buy
MA20
4,697.23Buy
4,710.42Buy
MA50
4,457.89Buy
4,493.01Buy
MA100
4,188.68Buy
4,276.03Buy
MA200
3,952.57Buy
4,059.18Buy
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 10-Day exponential moving average is 4809.84, making it a Buy.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 100-Day exponential moving average is 4276.03, making it a Buy.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 50-day simple moving average is 4457.89, creating a Buy signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 100-day simple moving average is 4188.68, creating a Buy signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) 200-day simple moving average is 3952.57, creating a Buy signal.

iFreeETF-Nikkei225(Quarterly Dividend Type) (2624) Technical Analysis

Oct 22, 2025, 02:53 AM
Name
Value
Action
RSI (14)
66.38
Neutral
STOCH (9,6)
70.15
Neutral
STOCHRSI (14)
79.23
Neutral
MACD (12,26)
130.34
Sell
ADX (14)
44.78
Neutral
Williams %R
-4.07
Sell
CCI (14)
107.41
Sell
ATR (14)
102.07
-
Ultimate Oscillator
58.79
Neutral
ROC
10.00
Buy
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Relative Strength Index (RSI) is 66.38, creating a Neutral signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Trend Strength Indicator (ADX) is 44.78, creating a Neutral signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Commodity Channel Index (CCI) is 107.41, creating a Sell signal.
iFreeETF-Nikkei225(Quarterly Dividend Type)’s (2624) Price Rate of Change (ROC) is 10.00, creating a Buy signal.

FAQ

Is 2624 a Buy, Hold, or Sell?
Based on 2624’s technical indicators, 2624 is a Buy.
    What is 2624’s RSI (14)?
    2624’s RSI (14) is 66.38, which suggests 2624 is a Neutral.
      What is 2624’s MACD?
      2624’s MACD is 130.34, which suggests 2624 is a Sell.
        What is 2624’s 5-day moving average?
        2624’s 5-day moving average is 4826.00, which suggests 2624 is a Buy.
          What is 2624’s 20-day moving average?
          2624 20-day moving average is 4697.23, which suggests 2624 is a Buy.
            What is 2624’s 50-day moving average?
            2624’s 50-day moving average is 4457.89, which suggests 2624 is a Buy.
              What is 2624’s 200-day moving average?
              2624’s 200-day moving average is 3952.57, which suggests 2624 is a Buy.
                What is 2624’s Williams % R (14)?
                2624’s Williams % R (14) is -4.07, which suggests 2624 is a Sell.
                  What is 2624’s CCI (14)?
                  2624’s CCI (14) is 107.41, which suggests 2624 is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement